US 2012/0071445 A1Published application

Combination Therapy for the Treatment of Multiple Myeloma

AssigneeCephalon, Inc.

InventorJames R. Berenson

Life of this patent

Estimating the term…

Abstract

The present invention provides a method for treating multiple myeloma in a subject, comprising the step of administering to the subject a combination of COMPOUND 1 and bortezomib. The invention further provides a method for treating multiple myeloma in a subject, comprising the step of administering to the subject a combination of COMPOUND 1 and melphalan.

Claims20

Dependent claims

A method for treating multiple myeloma in a subject, comprising the step of administering to the subject a combination of COMPOUND 1 and bortezomib

Dependencies are inferred from the claim text.

Facts

Application: 13/292,553Filed 9 Nov 2011
Priority: 27 May 2009
Published: 22 Mar 2012
Term ends: Not estimatedThe source records don’t support an estimate.

Classification5 codes

A61K 31/4422
Non condensed pyridines; Hydrogenated derivatives thereof: 1,4-Dihydropyridines, e.g. nifedipine, nicardipine
A61K 31/445
Non condensed pyridines; Hydrogenated derivatives thereof: non condensed piperidines, e.g. piperocaine
A61P 35/00
Antineoplastic agents
A61K
Medicines and medical preparations

Family

Application61/181,550Us provisional application · filed 27 May 2009
Application61/185,501Us provisional application · filed 9 Jun 2009
Application61/232,594Us provisional application · filed 10 Aug 2009
Application13/292,553Continuation
US 8,765,720 B2Related patent
US 2012/0071445 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results